Skip to content

Cryoneurolysis Versus Radiofrequency in Knee Osteoarthritis

Cryoneurolysis Versus Radiofrequency in Knee Osteoarthritis: A Randomised Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07664371
Enrollment
30
Registered
2026-06-24
Start date
2026-06-10
Completion date
2026-11-01
Last updated
2026-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

The project will evaluate the effectiveness of Cryoneurolysis versus radiofrequency procedures in adult patients who are resistant to traditional treatment for knee pain. They are a drug-free pain management procedure.

Detailed description

The main approach to OA management is pain control. Cryoneurolysis versus radiofrequency in decreasing knee pain.

Interventions

DEVICECryoneurolysis

Cryoneurolysis freezes nerves

DEVICEpulsed radiofrequency (RF)

radiofrequency (RF) uses electric pulses

uses cooled radiofrequency energy to deactivate pain-causing nerves

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

This is a prospective, randomised study. The closed envelop randomization method will be used for the randomization of the patients who will be also blinded to group allocation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. adults between the ages of 30 and 70 years with a clinical diagnosis of refractory knee OA who suffered from knee pain. 2. Patients who cannot afford intra-articular injections. 3. patients who had failed 2 different oral pain medications, and 6 weeks of physical therapy.

Exclusion criteria

1. Patients with OA show improvement in pain after physiotherapy. 2. patients evaluated by an orthopedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA. 3. pregnant patients. 4. patients on anticoagulation therapy, who were not permitted to stop anticoagulation. 5. patients with previous trauma, neurological or endocrine diseases like diabetes mellitus, and knee tumors; and patients with inflammatory arthritis. 6. people who had received an intra-articular knee injection within the last 6 months. 7. Patients with tendon tears, bursitis, or calcified tendonitis as proven by imaging.

Design outcomes

Primary

MeasureTime frameDescription
Change in visual analogue scale after interventionimmediately after interventionDecrement (clinical improvement) in visual analogue scale (VAS) immediately after intervention. The participant's knee discomfort was measured using a VAS. Participants were asked to score their level of pain on a 100-mm horizontal line, ranging from 0 to 100.

Countries

Egypt

Contacts

CONTACTAliaa Mamdouh Abdelaziz Farag, MD
aliaa.mamdouh@med.tanta.edu.eg+201069468486

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026